Trial intelligence / Profile preview

Intravenous dexamethasone versus budesonide nebulizer for neonatal respiratory distress syndrome

IRCT2016101917413N20Phase 3Completed

Sponsor
Islamic Azad University
Start
Jun 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of dexamethasone and budesonide in respiratory distress syndrome (RDS) (2 arms), sponsored by Islamic Azad University. Started Jun 2014; status: completed.

02

Drugs

dexamethasonebudesonide
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on IRCT2016101917413N20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016101917413N20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call